"Helicobacter pylori" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).
| Descriptor ID |
D016480
|
| MeSH Number(s) |
B03.440.500.550 B03.660.150.280.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Helicobacter pylori".
Below are MeSH descriptors whose meaning is more specific than "Helicobacter pylori".
This graph shows the total number of publications written about "Helicobacter pylori" by people in this website by year, and whether "Helicobacter pylori" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 3 | 0 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 3 | 0 | 3 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 2 | 3 |
| 2016 | 3 | 1 | 4 |
| 2017 | 39 | 11 | 50 |
| 2018 | 39 | 10 | 49 |
| 2019 | 18 | 4 | 22 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Helicobacter pylori" by people in Profiles.
-
The Role of Helicobacter pylori Infection in Coronavirus Disease 2019, Cause or Coincidence? J Pediatr Gastroenterol Nutr. 2021 10 01; 73(4):e106.
-
The Effect of Helicobacter pylori on the Presentation and Clinical Course of Coronavirus Disease 2019. J Pediatr Gastroenterol Nutr. 2021 10 01; 73(4):e106-e107.
-
Helicobacter pylori - 2021. Orv Hetil. 2021 08 08; 162(32):1275-1282.
-
The best is the enemy of the good: Time for a biopsy-sparing approach for Helicobacter pylori diagnosis and treatment in children in the COVID-19 era? Helicobacter. 2021 Aug; 26(4):e12826.
-
NAFLD and Infection, a Nuanced Relationship. Can J Gastroenterol Hepatol. 2021; 2021:5556354.
-
The Effect of Helicobacter pylori on the Presentation and Clinical Course of Coronavirus Disease 2019 Infection. J Pediatr Gastroenterol Nutr. 2021 04 01; 72(4):511-513.
-
Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2. J Immunol Methods. 2021 05; 492:112996.
-
Rogue antibodies could be driving severe COVID-19. Nature. 2021 02; 590(7844):29-31.
-
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses. Immunity. 2020 12 15; 53(6):1315-1330.e9.
-
A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone. Sci Rep. 2020 10 23; 10(1):18149.